Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

15.4K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.4K
Ligand Binding Sites02:40

Ligand Binding Sites

9.0K
9.0K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

15.4K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.4K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.2K
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Size-dependent superhalogenicity and ring currents of tantalum doped platinum clusters TaPt <sub><i>n</i>-1</sub> <sup>-/0</sup> (<i>n</i> = 2-21).

RSC advances·2026
Same author

Innovative Facial Contouring Using a Monopolar Radiofrequency Device with Continuous Water Cooling: An Integrated Clinical and Preclinical Study.

International journal of molecular sciences·2026
Same author

NaMgX<sub>3</sub> (X = Cl, Br) for solid electrolyte interphases: atomistic insights into defects, surfaces and doping strategies.

Physical chemistry chemical physics : PCCP·2026
Same author

Translational Evaluation of a Disodium Adenosine Monophosphate (AMP2Na)-Based Topical Formulation for Physiology-Aligned Skin Rejuvenation: Integrated In Vitro, Ex Vivo, and Clinical Evidence.

International journal of molecular sciences·2026
Same author

Effect of three-dimensional virtual modeling on surgical outcomes in robot-assisted partial nephrectomy for localized renal tumors: A propensity-matched analysis.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

From Aromatic to Antiaromatic: Charge-Induced Electronic Transformation and Unexpected Stability of B<sub>24</sub>Ni<sub>3</sub><sup></sup>.

The journal of physical chemistry. A·2026

Related Experiment Video

Updated: Mar 3, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.8K

Benchmarking the Ligand-HER2 Interactions Using Machine Learning and Molecular Dynamics Simulations.

Duc Toan Truong1,2, Quang Tung Dao3, Thi Thuy Mai Tran4

  • 1Laboratory for Chemical Computation and Modeling, Institute for Computational Science and Artificial Intelligence, Van Lang University, Ho Chi Minh City 70000, Vietnam.

ACS Omega
|March 2, 2026
PubMed
Summary
This summary is machine-generated.

Researchers identified key interactions between breast cancer's HER2 protein and inhibitors. A novel compound, lig233, shows significantly stronger binding than lapatinib, offering new avenues for HER2 inhibitor drug development.

More Related Videos

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

6.9K
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.4K

Related Experiment Videos

Last Updated: Mar 3, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.8K
Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

6.9K
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.4K

Area of Science:

  • Biochemistry
  • Computational Biology
  • Pharmacology

Background:

  • HER2 tyrosine kinase is a critical target in breast cancer therapy.
  • Understanding inhibitor-HER2 interactions is vital for developing effective treatments.
  • Existing therapies face challenges, necessitating novel inhibitor strategies.

Purpose of the Study:

  • To elucidate the molecular mechanism of inhibitor-HER2 interactions.
  • To identify novel potent anti-HER2 compounds.
  • To establish a benchmark for ligand-HER2 binding strength.

Main Methods:

  • Machine learning predictive regression model.
  • Atomistic molecular dynamics (MD) simulations.
  • Umbrella sampling MD method for binding free energy calculations.
  • Systematic mining of 8 million chemical compounds.

Main Results:

  • Identified 13 novel anti-HER2 candidate compounds.
  • Established electrostatic interactions with key residues (Lys753, Leu796, Thr798, Asp863, Asp880) as crucial for inhibitor strength.
  • Compound lig233 demonstrated exceptional binding free energy (-47 kcal/mol), exceeding that of lapatinib (-21 kcal/mol).
  • Lig233 forms hydrogen bonds with Asp863 and Asp880, indicating strong chemical bonds.

Conclusions:

  • Novel insights into inhibitor-HER2 binding mechanisms.
  • Lig233 represents a promising lead compound for next-generation HER2 inhibitors.
  • Findings can guide experimental development of more effective breast cancer therapies.